Study of Safety and Efficacy of an Oral Contraceptive
An Open Label Study of the Contraceptive Efficacy of Norethindrone and Ethinyl Estradiol.
1 other identifier
interventional
1,700
1 country
63
Brief Summary
This is a non-comparative study. the primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jun 2007
63 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2007
CompletedFirst Posted
Study publicly available on registry
May 24, 2007
CompletedStudy Start
First participant enrolled
June 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedResults Posted
Study results publicly available
January 24, 2011
CompletedApril 22, 2013
April 1, 2013
1.6 years
May 22, 2007
October 13, 2010
April 15, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pearl Index, 18-35 Years, MITT Population
Pregnancy rate in women 18-35 years old, Pearl Index - number of pregnancies per 100 women-years of treatment
13 cycles (28 days each), approximately 364 days
Secondary Outcomes (2)
Mean Number of Days of Intracyclic Bleeding & Spotting, Cycles 2-13, MITT Population
12 cycles (28 days each), approximately 336 days
Mean Median Duration (Days) of Intracyclic Bleeding & Spotting, Cycles 2-13, MITT Population
12 cycles (28 days each), approximately 336 days
Study Arms (1)
Norethindrone/ethinyl estradiol
EXPERIMENTAL1 tablet per day
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Women
- Age 18-45
- At risk for pregnancy
- History of regular cycles
You may not qualify if:
- Contraindications for use of hormonal contraception
- Conditions which affect the absorption or metabolism of steroid hormones
- BMI\>35
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Warner Chilcottlead
Study Sites (63)
Warner Chilcott Investigational Site
Chandler, Arizona, 85224, United States
Warner Chilcott Investigational Site
Phoenix, Arizona, 85032, United States
Warner Chilcott Investigational Site
Phoenix, Arizona, 85037, United States
Warner Chilcott Investigational Site
Phoenix, Arizona, 85050, United States
Warner Chilcott Investigational Site
Tempe, Arizona, 85282, United States
Warner Chilcott Investigational Site
Tucson, Arizona, 85712, United States
Warner Chilcott Investigational Site
San Diego, California, 92103, United States
Warner Chilcott Investigational Site
San Diego, California, 92108, United States
Warner Chilcott Investigational Site
Vista, California, 92083, United States
Warner Chilcott Investigational Site
Castle Rock, Colorado, 80108, United States
Warner Chilcott Investigational Site
Denver, Colorado, 80218, United States
Warner Chilcott Investigational Site
Lakewood, Colorado, 80228, United States
Warner Chilcott Investigational Site
Boynton Beach, Florida, 33472, United States
Warner Chilcott Investigational Site
Brooksville, Florida, 34613, United States
Warner Chilcott Investigational Site
Clearwater, Florida, 33759, United States
Warner Chilcott Investigational Site
Gainesville, Florida, 32607, United States
Warner Chilcott Investigational Site
Jacksonville, Florida, 32207, United States
Warner Chilcott Investigational Site
Leesburg, Florida, 34748, United States
Warner Chilcott Investigational Site
Miami, Florida, 33143, United States
Warner Chilcott Investigational Site
Miami, Florida, 33186, United States
Warner Chilcott Investigational Site
Pembroke Pines, Florida, 33021, United States
Warner Chilcott Investigational Site
St. Petersburg, Florida, 33709, United States
Warner Chilcott Investigational Site
West Palm Beach, Florida, 33401, United States
Warner Chilcott Investigational Site
West Palm Beach, Florida, 33409, United States
Warner Chilcott Investigational Site
Decatur, Georgia, 30034, United States
Warner Chilcott Investigational Site
Champaign, Illinois, 61820, United States
Warner Chilcott Investigational Site
Peoria, Illinois, 61615, United States
Warner Chilcott Investigational Site
Indianapolis, Indiana, 46250, United States
Warner Chilcott Investigational Site
Arkansas City, Kansas, 67005, United States
Warner Chilcott Investigational Site
Wichita, Kansas, 67207, United States
Warner Chilcott Investigational Site
Lexington, Kentucky, 40509, United States
Warner Chilcott Investigational Site
Louisville, Kentucky, 40291, United States
Warner Chilcott Investigational Site
Amite, Louisiana, 70422, United States
Warner Chilcott Investigational Site
Marrero, Louisiana, 70072, United States
Warner Chilcott Investigational Site
Chaska, Minnesota, 55318, United States
Warner Chilcott Investigational Site
Berlin, New Jersey, 08009, United States
Warner Chilcott Investigational Site
Edison, New Jersey, 08817, United States
Warner Chilcott Investigational Site
Lawrenceville, New Jersey, 08648, United States
Warner Chilcott Investigational Site
Moorestown, New Jersey, 08051, United States
Warner Chilcott Investigational Site
New York, New York, 10016, United States
Warner Chilcott Investigational Site
Cary, North Carolina, 27511, United States
Warner Chilcott Investigational Site
New Bern, North Carolina, 28562, United States
Warner Chilcott Investigational Site
Raleigh, North Carolina, 27612, United States
Warner Chilcott Investigational Site
Winston-Salem, North Carolina, 27103, United States
Warner Chilcott Investigational Site
Cleveland, Ohio, 44122, United States
Warner Chilcott Investigational Site
Oklahoma City, Oklahoma, 73112, United States
Warner Chilcott Investigational Site
Medford, Oregon, 97504, United States
Warner Chilcott Investigational Site
Philadelphia, Pennsylvania, 19114, United States
Warner Chilcott Investigational Site
Pittsburgh, Pennsylvania, 15206, United States
Warner Chilcott Investigational Site
Pottstown, Pennsylvania, 19464-3224, United States
Warner Chilcott Investigational Site
Columbia, South Carolina, 29201, United States
Warner Chilcott Investigational Site
Austin, Texas, 78748, United States
Warner Chilcott Investigational Site
Austin, Texas, 78759, United States
Warner Chilcott Investigational Site
Dallas, Texas, 75234, United States
Warner Chilcott Investigational Site
Houston, Texas, 77030, United States
Warner Chilcott Investigational Site
San Antonio, Texas, 78229, United States
Warner Chilcott Investigational Site
Magna, Utah, 84044, United States
Warner Chilcott Investigational Site
Salt Lake City, Utah, 84109, United States
Warner Chilcott Investigational Site
Salt Lake City, Utah, 84121, United States
Warner Chilcott Investigational Site
West Valley City, Utah, 84120, United States
Warner Chilcott Investigational Site
Norfolk, Virginia, 23507, United States
Warner Chilcott Investigational Site
Richmond, Virginia, 23233, United States
Warner Chilcott Investigational Site
Virginia Beach, Virginia, 23456, United States
MeSH Terms
Interventions
Results Point of Contact
- Title
- Grexan Wulff, Manager Regulatory Affairs
- Organization
- Warner Chilcott
Study Officials
- STUDY DIRECTOR
Herman Ellman
Sponsor GmbH
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2007
First Posted
May 24, 2007
Study Start
June 1, 2007
Primary Completion
January 1, 2009
Study Completion
February 1, 2009
Last Updated
April 22, 2013
Results First Posted
January 24, 2011
Record last verified: 2013-04